Lymph node dissection, the current standard surgical treatment for localized non-small cell lung cancers, may be unnecessary in certain screen-detected early stage cases , according to a study published in the March issue of the Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer.
The risk of nodal involvement is very low in early-stage cancers with a maximum standard uptake value (maxSUV) of 2.0 or a nodule smaller than 10 millimeters, researchers found.Science Brief thanks to EurekAlert.
Read more here:
Lymph node dissection is not essential in small screen-detected lung cancers, new research shows
Net News Publisher for Science News
Related articles
- High Levels of Circulating DNA May Signal Faster Progression of Lung Cancer (netnewspublisher.com)
- Anti-estrogen Medication Reduces Risk of Dying From Lung Cancer (netnewspublisher.com)
- Lung Societies Unveil New International Classification of Lung Adenocarcinoma (netnewspublisher.com)
